ClinicalTrials.gg
Active, not recruitingNCT01824745Updated Oct 22, 2026

Survivorship Care Planning in Improving the Quality of Life in Breast Cancer Survivors

An interventional study of educational intervention and counseling intervention in Breast Cancer and Cancer Survivor, sponsored by City of Hope Medical Center. Active, not recruiting at 2 sites in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by City of Hope Medical Center · Not applicable, Interventional, and Supportive care

How we know

Updated Oct 22, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 89 studies in Breast Neoplasms by City of Hope Medical Center — 17 open to participants now, 39 under way, 1 of them phase 3. Breast Neoplasms · City of Hope Medical Center.

Planned enrollment
12th of 76
100 · median 36
Started
2013
with 3 others
No phase
33 of 89
4 open now
Primary completion
2027-01
later than 17 of 38 live
Registered
48th of 89
by date

Among the 89 studies in Breast Neoplasms by City of Hope Medical Center, this one is the 12th largest by planned enrollment of the 76 interventional ones that give a count, is one of 4 that started in 2013, is one of 33 with no phase, reaches primary completion later than 17 of the 38 other live ones, and was the 48th registered.

Breast Neoplasms

14,855 studies on the registry are indexed under Breast Neoplasms; 3,321 are open to participants now.

Browse Breast Neoplasms studies →

Open to participants now

17 of the 89 studies in Breast Neoplasms by City of Hope Medical Center are open now, in 1 country. Recruiting first, the newest first:

12 more — sign in →

By country, each count listing its studies:

All 17 open studies →

Where they have run

Who these studies take

Of the 2,403 Breast Neoplasms studies recruiting now, 1,574 (66%) set no upper age limit and 591 (25%) stop at 75 or younger; 103 take children under 18; 215 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 89 studies in Breast Neoplasms by City of Hope Medical Center, or all of them as a file.
02

Study summary

This randomized pilot clinical trial studies survivorship care planning in improving the quality of life in breast cancer survivors. Survivorship care planning may reduce stress and improve the well-being and quality of life of cancer survivors.

Read the detailed description

PRIMARY OBJECTIVES:

I. Test the effectiveness of the navigation intervention and survivorship care plan (SCP)-breast cancer survivors (BCS) template booklet on accessing and adhering to SCP-BCS guidelines compared to the control group receiving usual care and the SCP-BCS template booklet.

SECONDARY OBJECTIVES:

I. Develop a clinically and psychosocially responsive SCP-breast cancer survivors (SCP-BCS) template in English and English-Spanish adopted from American Society of Clinical Oncology (ASCO)-SCP.

II. Assess the acceptability, utility and format preference (electronic vs paper) of the SCP-BCS template.

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM I: Participants receive SCP-BCS template booklet and receive counseling sessions with a patient navigator for 40 minutes twice weekly for 4 sessions.

ARM II: Participants receive SCP-BCS template booklet and receive standard follow-up care.

After completion so study treatment, participants are followed up at 6 and 12 months.

03

Conditions studied

  • Breast Cancer
  • Cancer Survivor

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • In early survivorship phase, defined as being post-surgery to ending of active treatment to 18 months post active treatment for stage 0-3 breast cancer (BCA)
  • Reside in Southern California
  • BCS treated at Kaiser, an health maintenance organization (HMO) provider, will be excluded since their SCP implementation project is underway
  • BCS will not be excluded based on cancer treatments received or a history of diagnosis of mild depression, anxiety, and hypertension and diabetes
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Arm I (SCP-BCS template booklet and counseling)

    Participants receive SCP-BCS template booklet and receive counseling sessions with a patient navigator for 40 minutes twice weekly for 4 sessions.

    Other: educational intervention · Other: counseling intervention · Procedure: quality-of-life assessment · Other: questionnaire administration

  • Active comparator
    Arm II (SCP-BCS template booklet)

    Participants receive SCP-BCS template booklet and receive standard follow-up care.

    Other: educational intervention · Procedure: standard follow-up care · Procedure: quality-of-life assessment · Other: questionnaire administration

Interventions

  • Othereducational intervention

    Receive the SCP-BCS template booklet

    Also known as: intervention, educational

  • Othercounseling intervention

    Receive counseling sessions with a patient navigator

    Also known as: counseling and communications studies

  • Procedurestandard follow-up care

    Receive standard follow-up care

  • Procedurequality-of-life assessment

    Ancillary studies

    Also known as: quality of life assessment

  • Otherquestionnaire administration

    Ancillary studies

06

What researchers measure

Primary outcomes

  1. Proportion of BCS accessing a SCP from their oncology provider

    Fisher's exact test will be used to test the null hypothesis (at least 40% of trial participants will have access to SCP).

    Time frame: At 6 months

Secondary outcomes

  1. Adherence to SCP guidelines

    Fisher's exact test will be used to test the null hypothesis (at least 25% of participants reporting adherence to SCP guidelines).

    Time frame: At 12 months

  2. Proportion of BCS accessing a SCP from their oncology provider

    Fisher's exact test will be used to test the null hypothesis (at least 60% of trial participants will have access to SCP).

    Time frame: At 12 months

Other outcomes

  1. Develop a clinically and psychosocially responsive SCP-BCS template in English and a linguistically response bilingual version (English-Spanish)

    The acceptability, utility, and format preference will also be assessed. A rating score will be generated for acceptability and utility and 95% confidence intervals for the proportion of BCS rating score at \>= 4 will be assessed.

    Time frame: Up to 12 months

07

Study locations

2 sites
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2013 (actual). Primary completion is estimated for Jan 2027, 158 months after the start.

Of 2,673 non-industry interventional studies with no phase under Breast Neoplasms, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 66. This study's planned 158 months is above that.

Counting every sponsor, half of 2,783 studies reached it within 33 months; a quarter within 15 and three quarters within 66.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 22, 2026: start Jul 2013 → Oct 2013, primary completion Oct 2026 → Jan 2027 and completion Oct 2026 → Jan 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 2, 2013
First posted
Apr 5, 2013
StartActual
Oct 8, 2013was Jul 2013
Primary completionEst.
Jan 1, 2027was Oct 2026
CompletionEst.
Jan 1, 2027was Oct 2026
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Jul 15, 2013→Oct 8, 2013 (actual)
Oct 22, 2026
Primary completion
Oct 1, 2026→Jan 1, 2027
Oct 22, 2026
Study completion
Oct 1, 2026→Jan 1, 2027
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    Start date Jul 15, 2013→Oct 8, 2013 (now actual)
    Primary completion Oct 1, 2026→Jan 1, 2027
    Study completion Oct 1, 2026→Jan 1, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT01824745
Responsible party
Sponsor
First posted
Apr 5, 2013
Start date
Oct 8, 2013
Primary completion
Jan 1, 2027 (estimated)
Completion
Jan 1, 2027 (estimated)
Last update
Oct 22, 2026

Study contacts

Kimlin Ashing-Giwa
principal investigator · City of Hope Medical Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion